Page 4 - Best Pancreatic cancer doctors: TOP 128 doctors

Prof. Klaus Kaczirek is a leading endocrine and oncologic surgeon, specializing in neuroendocrine tumors at Wiener Privatklinik.

• Over 25 years of experience of experience in endocrine surgery
• Professor of Surgery at the Medical University of Vienna
• Published extensively on endocrine tumor biology and minimally invasive surgery
• Deputy Head of the Department of General Surgery at Vienna General Hospital

Dr. Hossein Taghizadeh specializes in pancreatic and biliary cancers, integrating modern systemic therapies with personalized care at Wiener Privatklinik.

• Trained at Medical University of Vienna – one of Austria's top medical schools
• Expert in chemotherapy, targeted therapy, and immunotherapy for gastrointestinal tumors
• Focuses on evidence-based medicine and holistic patient support
• Works with advanced diagnostic tools for precise treatment planning

Prof. Dr. med. Karl J. Oldhafer is a leading expert in pancreatic, liver, and stomach cancer surgery at Asklepios Hospital Barmbek.

• Senior Consultant of General and Abdominal Surgery and Surgical Oncology
• Heads a Centre for Liver Diseases specializing in complex liver surgeries
• Uses advanced techniques like radioservice computer-navigated liver surgery
• Works with multidisciplinary teams including oncology and radiology specialists
• Specializes in minimally invasive abdominal surgery techniques

Associate Professor Tahsin Ozatli specializes in treating breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Experience from multiple oncology clinics including state and research hospitals
• Promoted to Associate Professor in 2016
• Studied medicine at Selcuk University in Konya, Turkey

Trained in advanced laparoscopic and bariatric surgery at Istanbul University – a leader in minimally invasive techniques for pancreatic cancer.

• Specialized in laparoscopic surgery since 2002
• Advanced training in laparoscopic bariatric and oncological cancer surgery
• Education from top Turkish medical institutions including Istanbul University

Professor Gul Alco specializes in radiation oncology for pancreatic cancer at Istanbul Medipol University.

• Over 31 years of experience of experience in radiation oncology
• Specializes in pancreatic cancer treatment
• Associate Professor and later Professor at Demiroglu Bilim University
• Extensive training in radiation oncology

Assoc. Prof. Nail Paksoy specializes in pancreatic cancer treatment at Medipol Bahçelievler Hospital, backed by extensive research and clinical trials.

• ESMO Board Certified in Medical Oncology
• Subinvestigator in pancreatic cancer clinical trials, including RECITE – AMGEN
• Published research on FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
• Fellowship-trained at Istanbul University Oncology Institute

Specializing in virotherapy – one of the newest immunology fields – Dr. Jaunalksne brings 49 years of experience of experience to pancreatic cancer treatment.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Focuses on innovative immunological approaches to cancer

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Specializes in pancreatic cancer at Medical Park Antalya, trained at Akdeniz University's prestigious medical oncology program.

• Completed medical oncology specialization in 2018
• Works at Antalya's leading Medical Park hospital complex
• Over 20 years of experience of medical experience
• Former roles at university teaching hospitals

Dr. Ozden brings over 27 years of experience of medical experience, specializing in pancreatic cancer treatment at VM Medical Park Pendik Hospital.

• Graduated from Istanbul University's prestigious Cerrahpaşa Faculty of Medicine
• Completed Medical Oncology subspecialty at Kocaeli University
• Extensive experience in internal medicine before specializing in oncology

Dr. Auala Hubert is Head of the Gastrointestinal Cancer Center at Hadassah Medical Center – a leader focused on treating cancers of the digestive system, including pancreatic cancer.

• 36 years of experience of specialized experience in oncology and radiotherapy
• Leads a dedicated multidisciplinary cancer center at a top university hospital
• Board-certified in both medical oncology and radiotherapy
• Active member of the national Committee for Gastrointestinal Cancer
• Holds dual degrees in medicine and psychology

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.